This is a fully automated system for determining six common antiepileptic drugs and two principal metabolites of carbamazepine in serum. it is based on "high-performance" liquid chromatography (HPLC), with column switching. TSKprecolumn BSA-ODS and TSKgel 005-1 20A (both from Toyo Soda) were used as the precolumn and analytical column, respectively. The former contains octadecylsilyl resins treated with bovine serum albumin (BSA), and does not adsorb macromolecules such as serum proteins but retains small lipophilic molecules such as antiepileptic drugs. Serum samples are directly injected onto the precolumn. After washing out the serum proteins from the precoiumn with sodium phosphate buffer, we switch the column connections to introduce the retained substances onto the analytical column and elute with a step-gradient of acetonitrile/sodium phosphate buffer. The high analyticai recovery (95-102%) and the reproducibilities (CV <5% within-run) indicate that this system is suitable for use in theraputic drug monitoring in clinical laboratories.
and hexobarbital (Tokyokasei, Tokyo) were used as external and internal standards. Acetonitrile ("HPLC grade") was from E. Merck, Darmstadt, F.RG.; other chemicals were AR grade.
Standard solutions. Standard stock solutions were prepared by dissolving sodium valproate (10 g/L) in distilled water and ethosuximide (10 g/L) and the other drugs (1 g/L) in acetonitrile. We removed the solution from the mixed standard solution under a stream of nitrogen at room temperature, then dissolved the residues in drug-free human serum.
Serum samples. We assayed patients' sera for which measurement of antiepileptic drugs had been requested.
Apparatus. All of the apparatus and all but one column were from Toyo Soda Manufacturing, Tokyo, Japan. The fully automated HPLC system consisted of a TOSO CP-8000 series chromatograph, a Model CCPM pump, a Model UV-8000 variable-wavelength detector, a Model CP-8000 chromatoprocessor, a Model PT-8000 column-switching valve system (two six-peint switching valves), and a programmable timer. We also used a Model AS-48 autosampler equipped with a cooling system and a Model CO-8000 column oven.
The To deproteinize patients' sera, we used acetonitrile containing 10 mg of hexobarbital (internal standard) per liter. After centrifuging the mixtures (1000 x g, 10 mm), we analyzed aliquots of the supernates by HPLC on the LiChrosorb RP-18 column. The chromatographic conditions were as follows: column temperature, room temperature; mobile phase, acetonitrile/sodiumphosphate buffer (0.1 mol/L, pH 5.7), 30/70 by vol; flow rate, 1.0 mL/min; and detection wavelength, 210 nm.
Immunological method. For comparison, we used the aca ifi discrete analyzer (DuPont Instruments, Wilmington, DE) and its associated reagents for antiepileptic drugs, without modification.
Automated HPLC with Column-Switching

Pretreatment.
We used TSKprecolumn BSA-ODS to deproteinize serum samples. After injecting 20 pL of serum sample onto the precolumn, which had been previously equilibratedwith sodium phosphate buffer (0.1 moIJL, pH 5.2), we washed the column for 8 mm with the same buffer at a flow rate of 1.0 mLlmin. Under these conditions, excess serum proteins were washed out, whereas antiepileptic drugs and the metabolites were completely adsorbed onto the precolumn. The substances retained on the precolumn were then quantitatively eluted within 4 mm with a mixture of acetonitrile and the sodium phosphate buffer (22/78 by vol), at a flow rate of 1.0 mL/min. We used the back-flush mode to elute the drugs and metabolites from the column. This minimized the volume of effluent containing the drugs and metabolites.
After switching the columns sothat the drugs and metabolites were eluted onto the analytical column, we returned the six-peint valve to its original pesition. was ethosuximide, primidone, CBZ-OH, CBZ-epo, phenobarbital, carbamazepine, phenytoin, and valproic acid. In Method B, it was ethosuximide, primidone, CBZ-OH, phenobarbital, CBZ-epe, phenytoin, carbainazepine, and valproic acid. Carbainazepine and carbainazepine metabolites were more efficiently retained on TSKgel ODS-120A than on TSKgel ODS-8OTM.
When serum of a patient treated with phenobarbital, phenytoin, carbamazepine, and valproic acid was analyzed by the two methods, two peaks other than the four peaks derived from the four administered drugs were clearly detected (Figures lB and 2B We studied absolute recovery of each compeund from serum that had ben subjected to various deproteimzation procedures. Human serum containing 20 pg of phenobarbital and phenytoin, 10 pg of carbainazepine, and 100 pg of valproic acid per milliliter was deproteinized by adding an equal volume of acetonitrile, perchloric acid (50 g/L), or trichloroacetic acid (100 g/L), and centrifuged at 1000 x g for 10 mm. We assayed 20 1zL of the supernate by the conventional HPLC without internal standard. The results (n 3) for phenobarbital, phenytoin, carbaniazepine, and valproic acid were as follows: acetonitrile, 94, 97, 94, 91%; perchioric acid, 84, 35,38, 79%; and trichioroacetic acid, 79, 28, 30, 61%, respectively. The recovery achieved by our column-switching procedure with TSKprecolumn BSA-ODS was comparable to that obtained on using deproteinization procedures with 50% acetonitrile and far superior to that with the other two procedures.
Calibration curves showed a good linear relation between peak area and analyte concentration in the range 2 to 20 mg of phenobarbital and phenytoin, 10 to 100 mg of vaiproic acid, 1 to 10 mg of carbamazepine, and 0.5 to 5 mg of CBZepo and CBZ-OH per liter (data not shown). Sensitivity (expressed as mV . s pTg) for ethosuximide, primidone, CBZ-OH, phenobarbital, CBZ-epo, phenytoin, carbamazepine, and valproic acid (20 L injection volume, 210 nm) was calculated to be 13, 75, 165, 108, 229, 117, 162, and 1 , respectively. Detection and determination limits of this method were about 10 and 20 mV s. Table 1 A comparison of the data (our method vs conventional HPLC or EMIT) by regression analysis showed a high correlation. . Carbamazepine values as determined by our method and conventional HPLC were 27% lower than those by the EMIT method. The discrepancies could be caused by the differences of carbamazepine standard preparations used, because, when carbamazepine (product of Ciba-Geigy) was used as a standard for EMIT method, the value was about 30% lower than the value determined by our HPLC method. Moreover, the cross reactivity of CBZ-epe with carbamazepine was about 10% with the EMIT method; however, that of CBZ-OH was negligible.
DIscussion
HPLC is not widely used to measure antiepileptic drugs in serum in clinical laboratories, owing to the healthhazardous pretreatment procedures. Column-switching techniques overcome this disadvantage by direct injection of serum onto the chromatographic column. Pretreatment precolumns such as gel permeation (14) or reversed-phase columns (12, 13) have been used for column-switching techniques including direct injection of biological fluids without sample pretreatment. When a gel-permeation column is used as the precolumn, the column-switching program should be carefully set to minimize the volume of effluent from the precolumn if recovery and reproducibility There were, however, some differences in chromatographic behaviors of the drugs in the two types of reversed-phase column. The resins of TSKgel ODS-8OTM are coated with an end-capped monolayer ODS on 8-nm (pore size) silica gel, while those of TSKgel ODS-120A have a non-end-capped polylayer ODS on 12-nm (pore size) silica gel. The differences in the chromatographic behaviors of carbamazepine and CBZ-epe may be caused by unreacted silanol groups. Despite the slight tailing of the peaks and low resolution, TSKge1 ODS-120A column was better than TSKgel ODS-8OTM for measurement of antiepileptic drugs in the case of concurrent administration of phenobarbital and carbamazepine, because a metabolite, CBZ-epe, is clearly separated from phenobarbital by use of TSKgel ODS-120A.
The values for antiepileptic drugs in patients' sera obtained by our method coincided well with those by conventional HPLC and EMIT methods except for the carbamazepine values by EMIT method. The reason for the different values for carbamazepine by the two methods is caused by the external standards. The determination of vaiproic acid (<20 pglmL) was unreliable because of low sensitivity for vaiproic acid; the injection volume would be better increased to 100 pL. Similar results for analytical recovery and lifetime of the columns were obtained by injecting 200-pL serum samples. Over 100 serum samples could be assayed with no deterioration of precolumn or analytical column; however, the end-fittings of the columns should be replaced after each 50 samples.
